Published in J Pharm Sci on February 01, 1980
Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients. Clin Pharmacol Ther (2007) 1.08
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function. J Clin Pharmacol (1997) 0.95
Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1985) 0.94
High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. J Chromatogr B Biomed Appl (1996) 0.94
Quantitative assay of diclofenac in biological material by gas-liquid chromatography. J Chromatogr (1975) 0.93
Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther (1997) 0.93
Determination of artemether and its metabolite, dihydroartemisinin, in plasma by high-performance liquid chromatography and electrochemical detection in the reductive mode. J Chromatogr B Biomed Sci Appl (1997) 0.90
[The percutaneous absorption of diclofenac]. Arzneimittelforschung (1986) 0.90
Gas chromatographic determination of amantadine hydrochloride (Symmetrel) in human plasma and urine. J Chromatogr (1980) 0.88
Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations. Am Heart J (1989) 0.88
Gas chromatographic determination of oxprenolol in human plasma. J Chromatogr (1983) 0.88
Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids. J Pharm Sci (1994) 0.88
Gas chromatographic determination of metoprolol in human plasma. J Chromatogr (1983) 0.86
Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection. J Chromatogr (1988) 0.85
Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos (1994) 0.85
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Clin Cancer Res (1999) 0.82
Gas chromatographic determination of phenazone derivatives in human plasma. II. Propyphenazone. J Chromatogr (1978) 0.82
Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks. Int J Clin Pharmacol Ther (2008) 0.82
Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. Eur J Clin Pharmacol (1997) 0.82
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol (1993) 0.81
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. Int J Clin Pharmacol Ther (2007) 0.80
GLC determination of free and conjugated triclosan in human plasma and urine. J Pharm Sci (1977) 0.80
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Eur J Clin Pharmacol (1994) 0.79
Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919). Eur J Clin Pharmacol (2001) 0.79
Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Sci Appl (1997) 0.79
Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration. Biopharm Drug Dispos (1998) 0.78
Determination of diclofenac in plasma and urine by capillary gas chromatography-mass spectrometry with possible simultaneous determination of deuterium-labelled diclofenac. J Chromatogr (1991) 0.77
Simultaneous determination of clomipramine and its N-desmethyl metabolite in human whole blood by capillary gas chromatography with mass-selective detection. J Chromatogr (1988) 0.76
Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects. J Clin Pharmacol (2001) 0.76
Pharmacokinetics of chlorthalidone in the elderly after single and multiple doses. Br J Clin Pharmacol (1983) 0.75
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. Br J Clin Pharmacol (1984) 0.75
Influence of exercise on nitroglycerin plasma concentrations after transdermal application. Br J Clin Pharmacol (1990) 0.75
Quantitative determination of norethisterone acetate in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr A (1996) 0.75
Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. Eur J Drug Metab Pharmacokinet (1991) 0.75
Simultaneous determination of isosorbide dinitrate and its mononitrate metabolites in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr B Biomed Appl (1996) 0.75
Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol (1989) 0.75
Determination of the two dinitrate metabolites of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1987) 0.75
[Use of presynaptic alpha-mimetics for withdrawal in heroin addicts]. Ann Med Interne (Paris) (1985) 0.75
[Cyclic-AMP]. Pathol Biol (Paris) (1970) 0.75
Determination of acenocoumarol in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1994) 0.75
[Transport of sodium diclofenac into synovial fluid]. Therapie (1984) 0.75
Determination of oxyphenbutazone in human plasma by high-performance liquid chromatography. J Chromatogr (1983) 0.75
Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. J Pharm Sci (1980) 0.75
Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers. Eur J Clin Pharmacol (1995) 0.75
Gas chromatographic determination of phentolamine (Regitine) in human plasma and urine. J Chromatogr (1981) 0.75
Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1995) 0.75
Determination of pirprofen in biological material by gas-liquid chromatography with nitrogen-specific and electron-capture detection. J Chromatogr (1984) 0.75
Gas chromatographic determination of valproic acid in human plasma. J Chromatogr (1980) 0.75
Stereospecific high-performance liquid chromatographic determination of an S(-)-benzopyran methyl ester derivative (CGP 50 068), its (-)-carboxylic acid metabolite (CGP 55 461) and the related (+)-enantiomer (CGP 54 228) in human and dog plasma. J Chromatogr B Biomed Appl (1995) 0.75
Bioequivalence assessment: a pharmaceutical industry perspective. Eur J Drug Metab Pharmacokinet (1996) 0.75
Gas chromatographic determination of maprotiline and its N-desmethyl metabolite in human blood using nitrogen detection. J Chromatogr (1980) 0.75
[Comparative elimination of pirprofen from the plasma and synovial fluid of the knee. 26 cases]. Presse Med (1983) 0.75
[Blood concentrations of maprotiline in depressive patients]. Encephale (1989) 0.75
Simultaneous determination of pirprofen and its metabolite, the pyrrole derivative, in plasma by high-performance liquid chromatography. J Chromatogr (1985) 0.75
Determination of the (+)- and (-)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography. J Chromatogr (1987) 0.75
Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr (1984) 0.75
Determination of isosorbide as a metabolite of isosorbide dinitrate in human urine by capillary gas chromatography with electron-capture detection. J Chromatogr (1983) 0.75
[Drug abuse and HIV in the hospital]. Soins Psychiatr (1990) 0.75
Gas chromatographic determination of clioquinol (Vioform) in human plasma. J Chromatogr (1981) 0.75
GLC determination of phenylbutazone in human plasma. J Pharm Sci (1978) 0.75
Gas chromatographic determination of phenazone derivatives in human plasma. I. Aminophenazone. J Chromatogr (1978) 0.75
The absence of a pharmacokinetic interaction between aspirin and the angiotensin-converting enzyme inhibitor benazepril in healthy volunteers. Biopharm Drug Dispos (1994) 0.75
Gas chromatographic determination of isosorbide dinitrate in human plasma and urine. J Chromatogr (1982) 0.75
[Effect of 3 antacids on the bioavailability of pirprofen]. Therapie (1984) 0.75
High-performance liquid chromatographic determination of sulphathiazole in human plasma and urine. J Chromatogr (1980) 0.75
Gas chromatographic determination of low concentrations of benzoic acid in human plasma and urine. J Chromatogr (1980) 0.75
Biotransformation of tribenoside into benzoic acid in man. Eur J Drug Metab Pharmacokinet (1982) 0.75
Gas chromatographic determination of N-desmethyl-propyphenazone, a metabolite of propyphenazone, in human urine. J Chromatogr (1980) 0.75